Literature DB >> 5322938

Allopurinol in the treatment of gout.

R W Rundles, E N Metz, H R Silberman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5322938     DOI： 10.7326/0003-4819-64-2-229

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  36 in total

1.  Diet and alcohol in gout.

Authors: 
Journal:  Br Med J       Date:  1967-09-02

2.  Predicting allopurinol response in patients with gout.

Authors:  Daniel F B Wright; Stephen B Duffull; Tony R Merriman; Nicola Dalbeth; Murray L Barclay; Lisa K Stamp
Journal:  Br J Clin Pharmacol       Date:  2015-12-29       Impact factor: 4.335

3.  Nobel lecture in physiology or medicine--1988. The purine path to chemotherapy.

Authors:  G B Elion
Journal:  In Vitro Cell Dev Biol       Date:  1989-04

4.  Allopurinol-hypersensitivity vasculitis and liver damage.

Authors:  T D Boyer; N Sun; T B Reynolds
Journal:  West J Med       Date:  1977-02

5.  [Diagnosis and management of gout in Austria. Survey of current practice considering the EULAR recommendations].

Authors:  J Sautner
Journal:  Z Rheumatol       Date:  2014-11       Impact factor: 1.372

6.  Understanding the dose-response relationship of allopurinol: predicting the optimal dosage.

Authors:  Garry G Graham; Diluk R W Kannangara; Sophie L Stocker; Ian Portek; Kevin D Pile; Praveen L Indraratna; Indira Datta; Kenneth M Williams; Richard O Day
Journal:  Br J Clin Pharmacol       Date:  2013-12       Impact factor: 4.335

Review 7.  Management of acute and chronic gouty arthritis: present state-of-the-art.

Authors:  Naomi Schlesinger
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Effects of the Dietary Approaches to Stop Hypertension (DASH) Diet and Sodium Intake on Serum Uric Acid.

Authors:  Stephen P Juraschek; Allan C Gelber; Hyon K Choi; Lawrence J Appel; Edgar R Miller
Journal:  Arthritis Rheumatol       Date:  2016-12       Impact factor: 10.995

Review 9.  Emerging molecular mediators and targets for age-related skeletal muscle atrophy.

Authors:  Lemuel A Brown; Steve D Guzman; Susan V Brooks
Journal:  Transl Res       Date:  2020-03-10       Impact factor: 7.012

Review 10.  Management of hyperuricemia in gout: focus on febuxostat.

Authors:  Mattheus K Reinders; Tim L Th A Jansen
Journal:  Clin Interv Aging       Date:  2010-02-02       Impact factor: 4.458
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.